{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:05:06Z","timestamp":1783094706603,"version":"3.54.6"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515010096"],"award-info":[{"award-number":["2021A1515010096"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010243"],"award-info":[{"award-number":["2023A1515010243"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515010717"],"award-info":[{"award-number":["2022A1515010717"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009812","name":"Chinese Society of Clinical Oncology","doi-asserted-by":"publisher","award":["Y-HR2018-319"],"award-info":[{"award-number":["Y-HR2018-319"]}],"id":[{"id":"10.13039\/501100009812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009812","name":"Chinese Society of Clinical Oncology","doi-asserted-by":"publisher","award":["Y-L2017-002"],"award-info":[{"award-number":["Y-L2017-002"]}],"id":[{"id":"10.13039\/501100009812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009812","name":"Chinese Society of Clinical Oncology","doi-asserted-by":"publisher","award":["Y-JS2019-009"],"award-info":[{"award-number":["Y-JS2019-009"]}],"id":[{"id":"10.13039\/501100009812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","award":["19ykpy180"],"award-info":[{"award-number":["19ykpy180"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","award":["YTP-SYSUCC-0042"],"award-info":[{"award-number":["YTP-SYSUCC-0042"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","award":["201313"],"award-info":[{"award-number":["201313"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009659","name":"Guangzhou Medical University","doi-asserted-by":"publisher","award":["202011-103"],"award-info":[{"award-number":["202011-103"]}],"id":[{"id":"10.13039\/100009659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009659","name":"Guangzhou Medical University","doi-asserted-by":"publisher","award":["202301-314"],"award-info":[{"award-number":["202301-314"]}],"id":[{"id":"10.13039\/100009659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009659","name":"Guangzhou Medical University","doi-asserted-by":"publisher","award":["202011-103"],"award-info":[{"award-number":["202011-103"]}],"id":[{"id":"10.13039\/100009659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009659","name":"Guangzhou Medical University","doi-asserted-by":"publisher","award":["202301-314"],"award-info":[{"award-number":["202301-314"]}],"id":[{"id":"10.13039\/100009659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002628"],"award-info":[{"award-number":["82002628"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32070592"],"award-info":[{"award-number":["32070592"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016691","name":"Guangdong Provincial Pearl River Talents Program","doi-asserted-by":"publisher","award":["2019QN01Y183"],"award-info":[{"award-number":["2019QN01Y183"]}],"id":[{"id":"10.13039\/100016691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>LARC patients commonly receive adjuvant therapy, however, hidden micrometastases still limit the improvement of OS. This study aims to investigate the impact of VASN in rectal cancer with pulmonary metastasis and understand the underlying molecular mechanisms to guide adjuvant chemotherapy selection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Sequencing data from rectal cancer patients with pulmonary metastasis from Sun Yat-sen University Cancer Center (SYSUCC) and publicly available data were meticulously analyzed. The functional role of VASN in pulmonary metastasis was validated in vivo and in vitro. Coimmunoprecipitation (co-IP), immunofluorescence, and rescue experiments were conducted to unravel potential molecular mechanisms of VASN. Moreover, VASN expression levels in tumor samples were examined and analyzed for their correlations with pulmonary metastasis status, tumor stage, adjuvant chemotherapy benefit, and survival outcome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our study revealed a significant association between high VASN expression and pulmonary metastasis in LARC patients. Experiments in vitro and in vivo demonstrated that VASN could promote the cell proliferation, metastasis, and drug resistance of colorectal cancer. Mechanistically, VASN interacts with the NOTCH1 protein, leading to concurrent activation of the NOTCH and MAPK pathways. Clinically, pulmonary metastasis and advanced tumor stage were observed in 90% of VASN-positive patients and 53.5% of VASN-high patients, respectively, and VASN-high patients had a lower five-year survival rate than VASN-low patients (26.7% vs. 83.7%). Moreover, the Cox analysis and OS analysis indicated that VASN was an independent prognostic factor for OS (HR\u2009=\u20097.4, P value\u2009&lt;\u20090.001) and a predictor of adjuvant therapy efficacy in rectal cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study highlights the role of VASN in decreasing drug sensitivity and activating the NOTCH and MAPK pathways, which leads to tumorigenesis and pulmonary metastasis. Both experimental and clinical data support that rectal cancer patients with VASN overexpression detected in biopsies have a higher risk of pulmonary metastasis and adjuvant chemotherapy resistance.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-024-05473-4","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T10:02:21Z","timestamp":1722938541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Vasorin (VASN) overexpression promotes pulmonary metastasis and resistance to adjuvant chemotherapy in patients with locally advanced rectal cancer"],"prefix":"10.1186","volume":"22","author":[{"given":"Da","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-hai","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z. Z.","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Xing","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxiu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. X.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"issue":"6","key":"5473_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"Cancer J Clin"},{"issue":"12","key":"5473_CR2","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/bjs.11242","volume":"106","author":"O Peacock","year":"2019","unstructured":"Peacock O, Waters PS, Bressel M, Lynch AC, Wakeman C, Eglinton T, et al. Prognostic factors and patterns of failure after surgery for T4 rectal cancer in the beyond total mesorectal excision era. Br J Surg. 2019;106(12):1685\u201396. https:\/\/doi.org\/10.1002\/bjs.11242.","journal-title":"Br J Surg"},{"issue":"11","key":"5473_CR3","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMoa060829","volume":"355","author":"J-F Bosset","year":"2006","unstructured":"Bosset J-F, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355(11):1114\u201323.","journal-title":"N Engl J Med"},{"issue":"2","key":"5473_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.radonc.2014.10.006","volume":"113","author":"A Sainato","year":"2014","unstructured":"Sainato A, Cernusco Luna Nunzia V, Valentini V, De Paoli A, Maurizi ER, Lupattelli M, et al. No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): long term results of a randomized trial (I-CNR-RT). Radiother Oncol. 2014;113(2):223\u20139. https:\/\/doi.org\/10.1016\/j.radonc.2014.10.006.","journal-title":"Radiother Oncol"},{"issue":"4","key":"5473_CR5","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/annonc\/mdu560","volume":"26","author":"AJ Breugom","year":"2015","unstructured":"Breugom AJ, van Gijn W, Muller EW, Berglund A, van den Broek CBM, Fokstuen T, et al. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial. Ann Oncol. 2015;26(4):696\u2013701. https:\/\/doi.org\/10.1093\/annonc\/mdu560.","journal-title":"Ann Oncol"},{"issue":"9604","key":"5473_CR6","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1016\/S0140-6736(07)61866-2","volume":"370","author":"G Quasar Collaborative","year":"2007","unstructured":"Quasar Collaborative G, Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet. 2007;370(9604):2020\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(07)61866-2.","journal-title":"Lancet"},{"issue":"35","key":"5473_CR7","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1200\/JCO.2015.63.4238","volume":"33","author":"T Andre","year":"2015","unstructured":"Andre T, de Gramont A, Vernerey D, Chibaudel B, Bonnetain F, Tijeras-Raballand A, et al. Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III Colon cancer: updated 10-Year survival and outcomes according to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study. J Clin Oncol. 2015;33(35):4176\u201387. https:\/\/doi.org\/10.1200\/JCO.2015.63.4238.","journal-title":"J Clin Oncol"},{"issue":"11","key":"5473_CR8","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1200\/JCO.2010.33.6297","volume":"29","author":"DG Haller","year":"2011","unstructured":"Haller DG, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E, et al. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol. 2011;29(11):1465\u201371. https:\/\/doi.org\/10.1200\/JCO.2010.33.6297.","journal-title":"J Clin Oncol"},{"issue":"12","key":"5473_CR9","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/S1470-2045(20)30527-1","volume":"21","author":"T Andre","year":"2020","unstructured":"Andre T, Meyerhardt J, Iveson T, Sobrero A, Yoshino T, Souglakos I, et al. Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials. Lancet Oncol. 2020;21(12):1620\u20139. https:\/\/doi.org\/10.1016\/S1470-2045(20)30527-1.","journal-title":"Lancet Oncol"},{"issue":"6024","key":"5473_CR10","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer CL, Weinberg RA. A perspective on Cancer Cell Metastasis. Science. 2011;331(6024):1559\u201364. https:\/\/doi.org\/10.1126\/science.1203543.","journal-title":"Science"},{"key":"5473_CR11","doi-asserted-by":"publisher","unstructured":"Kosmider S. Lara Lipton. Adjuvant therapies for colorectal cancer. World J Gastroenterol 2007; 28;13(28):3799\u2009\u2013\u2009805 https:\/\/doi.org\/10.3748\/wjg.v13.i28.3799.","DOI":"10.3748\/wjg.v13.i28.3799"},{"key":"5473_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ebiom.2019.01.050","volume":"40","author":"DS Bhullar","year":"2019","unstructured":"Bhullar DS, Barriuso J, Mullamitha S, Saunders MP, O\u2019Dwyer ST, Aziz O. Biomarker concordance between primary colorectal cancer and its metastases. EBioMedicine. 2019;40:363\u201374. https:\/\/doi.org\/10.1016\/j.ebiom.2019.01.050.","journal-title":"EBioMedicine"},{"key":"5473_CR13","doi-asserted-by":"publisher","first-page":"29765","DOI":"10.1038\/srep29765","volume":"6","author":"M Riihimaki","year":"2016","unstructured":"Riihimaki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016;6:29765. https:\/\/doi.org\/10.1038\/srep29765.","journal-title":"Sci Rep"},{"issue":"1","key":"5473_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. Cancer J Clin. 2022;72(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"Cancer J Clin"},{"key":"5473_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00384-019-03434-8","volume":"35","author":"Y Ge","year":"2020","unstructured":"Ge Y, Lei S, Cai B, Gao X, Wang G, Wang L, et al. Incidence and prognosis of pulmonary metastasis in colorectal cancer: a population-based study. Int J Colorectal Dis. 2020;35:223\u201332.","journal-title":"Int J Colorectal Dis"},{"key":"5473_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00834-2","author":"L Yang","year":"2023","unstructured":"Yang L, Yang J, Kleppe A, Danielsen HE, Kerr DJ. Personalizing adjuvant therapy for patients with colorectal cancer. Nat Rev Clin Oncol. 2023. https:\/\/doi.org\/10.1038\/s41571-023-00834-2.","journal-title":"Nat Rev Clin Oncol"},{"key":"5473_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2023.08.004","author":"M Schostak","year":"2023","unstructured":"Schostak M, Bradbury A, Briganti A, Gonzalez D, Gomella L, Mateo J, et al. Practical Guidance on establishing a molecular testing pathway for alterations in homologous recombination repair genes in clinical practice for patients with metastatic prostate Cancer. Eur Urol Oncol. 2023. https:\/\/doi.org\/10.1016\/j.euo.2023.08.004.","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"5473_CR18","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41591-022-02134-1","volume":"29","author":"S Foersch","year":"2023","unstructured":"Foersch S, Glasner C, Woerl AC, Eckstein M, Wagner DC, Schulz S, et al. Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer. Nat Med. 2023;29(2):430\u20139. https:\/\/doi.org\/10.1038\/s41591-022-02134-1.","journal-title":"Nat Med"},{"issue":"10135","key":"5473_CR19","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","volume":"391","author":"F Pages","year":"2018","unstructured":"Pages F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, et al. International validation of the consensus immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet. 2018;391(10135):2128\u201339. https:\/\/doi.org\/10.1016\/S0140-6736(18)30789-X.","journal-title":"Lancet"},{"issue":"10","key":"5473_CR20","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1002\/jcp.30838","volume":"237","author":"L Louvet","year":"2022","unstructured":"Louvet L, Lenglet G, Krautzberger AM, Mentaverri R, Hague F, Kowalewski C, et al. Vasorin plays a critical role in vascular smooth muscle cells and arterial functions. J Cell Physiol. 2022;237(10):3845\u201359. https:\/\/doi.org\/10.1002\/jcp.30838.","journal-title":"J Cell Physiol"},{"issue":"1","key":"5473_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.bbrc.2005.08.071","volume":"336","author":"L Chen","year":"2005","unstructured":"Chen L, Yao JH, Zhang SH, Wang L, Song HD, Xue JL. Slit-like 2, a novel zebrafish slit homologue that might involve in zebrafish central neural and vascular morphogenesis. Biochem Biophys Res Commun. 2005;336(1):364\u201371. https:\/\/doi.org\/10.1016\/j.bbrc.2005.08.071.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5\u20136","key":"5473_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.gep.2012.02.003","volume":"12","author":"AM Krautzberger","year":"2012","unstructured":"Krautzberger AM, Kosiol B, Scholze M, Schrewe H. Expression of vasorin (Vasn) during embryonic development of the mouse. Gene Expr Patterns. 2012;12(5\u20136):167\u201371. https:\/\/doi.org\/10.1016\/j.gep.2012.02.003.","journal-title":"Gene Expr Patterns"},{"issue":"16","key":"5473_CR23","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1038\/onc.2010.565","volume":"30","author":"J Malapeira","year":"2011","unstructured":"Malapeira J, Esselens C, Bech-Serra JJ, Canals F, Arribas J. ADAM17 (TACE) regulates TGFbeta signaling through the cleavage of vasorin. Oncogene. 2011;30(16):1912\u201322. https:\/\/doi.org\/10.1038\/onc.2010.565.","journal-title":"Oncogene"},{"issue":"8","key":"5473_CR24","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1111\/cas.14103","volume":"110","author":"W Liang","year":"2019","unstructured":"Liang W, Guo B, Ye J, Liu H, Deng W, Lin C, et al. Vasorin stimulates malignant progression and angiogenesis in glioma. Cancer Sci. 2019;110(8):2558\u201372. https:\/\/doi.org\/10.1111\/cas.14103.","journal-title":"Cancer Sci"},{"issue":"27","key":"5473_CR25","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1200\/JCO.2016.66.6198","volume":"34","author":"Y Deng","year":"2016","unstructured":"Deng Y, Chi P, Lan P, Wang L, Chen W, Cui L, et al. Modified FOLFOX6 with or without radiation versus fluorouracil and leucovorin with radiation in neoadjuvant treatment of locally advanced rectal cancer: initial results of the Chinese FOWARC multicenter, open-label, randomized three-arm phase III trial. J Clin Oncol. 2016;34(27):3300\u20137.","journal-title":"J Clin Oncol"},{"key":"5473_CR26","doi-asserted-by":"crossref","unstructured":"Guo X, Chen F, Gao F, Li L, Liu K, You L et al. CNSA: a data repository for archiving omics data. Database 2020;2020.","DOI":"10.1093\/database\/baaa055"},{"issue":"8","key":"5473_CR27","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ctrv.2015.06.007","volume":"41","author":"K Tamas","year":"2015","unstructured":"Tamas K, Walenkamp AM, de Vries EG, van Vugt MA, Beets-Tan RG, van Etten B, et al. Rectal and colon cancer: not just a different anatomic site. Cancer Treat Rev. 2015;41(8):671\u20139. https:\/\/doi.org\/10.1016\/j.ctrv.2015.06.007.","journal-title":"Cancer Treat Rev"},{"key":"5473_CR28","doi-asserted-by":"publisher","unstructured":"Paschke S, Jafarov S, Staib L, Kreuser ED, Maulbecker-Armstrong C, Roitman M, et al. Are Colon and rectal Cancer two different tumor entities? A proposal to abandon the term colorectal Cancer. Int J Mol Sci. 2018;19(9). https:\/\/doi.org\/10.3390\/ijms19092577.","DOI":"10.3390\/ijms19092577"},{"issue":"5","key":"5473_CR29","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H, Cao M, Sun D, He S, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584\u201390. https:\/\/doi.org\/10.1097\/CM9.0000000000002108.","journal-title":"Chin Med J (Engl)"},{"issue":"9","key":"5473_CR30","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1001\/jamaoncol.2016.2314","volume":"2","author":"N Song","year":"2016","unstructured":"Song N, Pogue-Geile KL, Gavin PG, Yothers G, Kim SR, Johnson NL, et al. Clinical outcome from oxaliplatin treatment in stage II\/III Colon cancer according to intrinsic subtypes: secondary analysis of NSABP C-07\/NRG oncology Randomized Clinical Trial. JAMA Oncol. 2016;2(9):1162\u20139. https:\/\/doi.org\/10.1001\/jamaoncol.2016.2314.","journal-title":"JAMA Oncol"},{"issue":"1","key":"5473_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New dimensions. Cancer Discov. 2022;12(1):31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059.","journal-title":"Cancer Discov"},{"issue":"4","key":"5473_CR32","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta GP, Massagu\u00e9 J. Cancer Metastasis: building a Framework. Cell. 2006;127(4):679\u201395. https:\/\/doi.org\/10.1016\/j.cell.2006.11.001.","journal-title":"Cell"},{"key":"5473_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2019.07.018","volume":"60","author":"H Allgayer","year":"2020","unstructured":"Allgayer H, Leupold JH, Patil N. Defining the Metastasome: perspectives from the genome and molecular landscape in colorectal cancer for metastasis evolution and clinical consequences. Sem Cancer Biol. 2020;60:1\u201313. https:\/\/doi.org\/10.1016\/j.semcancer.2019.07.018.","journal-title":"Sem Cancer Biol"},{"issue":"11","key":"5473_CR34","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41568-020-00300-6","volume":"20","author":"CA Klein","year":"2020","unstructured":"Klein CA. Cancer progression and the invisible phase of metastatic colonization. Nat Rev Cancer. 2020;20(11):681\u201394. https:\/\/doi.org\/10.1038\/s41568-020-00300-6.","journal-title":"Nat Rev Cancer"},{"key":"5473_CR35","doi-asserted-by":"publisher","unstructured":"Delattre J-F, Selcen Oguz Erdogan A, Cohen R, Shi Q, Emile J-F, Taieb J, et al. A comprehensive overview of tumour deposits in colorectal cancer: towards a next TNM classification. Cancer Treat Rev. 2022;103. https:\/\/doi.org\/10.1016\/j.ctrv.2021.102325.","DOI":"10.1016\/j.ctrv.2021.102325"},{"issue":"2","key":"5473_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41571-020-0422-y","volume":"18","author":"A Lugli","year":"2021","unstructured":"Lugli A, Zlobec I, Berger MD, Kirsch R, Nagtegaal ID. Tumour budding in solid cancers. Nat Rev Clin Oncol. 2021;18(2):101\u201315. https:\/\/doi.org\/10.1038\/s41571-020-0422-y.","journal-title":"Nat Rev Clin Oncol"},{"key":"5473_CR37","doi-asserted-by":"publisher","first-page":"109414","DOI":"10.1016\/j.cellsig.2019.109414","volume":"64","author":"TTD Luong","year":"2019","unstructured":"Luong TTD, Estepa M, Boehme B, Pieske B, Lang F, Eckardt KU, et al. Inhibition of vascular smooth muscle cell calcification by vasorin through interference with TGFbeta1 signaling. Cell Signal. 2019;64:109414. https:\/\/doi.org\/10.1016\/j.cellsig.2019.109414.","journal-title":"Cell Signal"},{"issue":"8","key":"5473_CR38","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1002\/ijc.31891","volume":"144","author":"HL Yeo","year":"2019","unstructured":"Yeo HL, Fan TC, Lin RJ, Yu JC, Liao GS, Chen ES, et al. Sialylation of vasorin by ST3Gal1 facilitates TGF-beta1-mediated tumor angiogenesis and progression. Int J Cancer. 2019;144(8):1996\u20132007. https:\/\/doi.org\/10.1002\/ijc.31891.","journal-title":"Int J Cancer"},{"issue":"suppl4","key":"5473_CR39","doi-asserted-by":"publisher","first-page":"iv22","DOI":"10.1093\/annonc\/mdx224","volume":"28","author":"R Glynne-Jones","year":"2017","unstructured":"Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rodel C, Cervantes A, et al. Rectal cancer: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl4):iv22\u201340. https:\/\/doi.org\/10.1093\/annonc\/mdx224.","journal-title":"Ann Oncol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05473-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05473-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05473-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T10:06:27Z","timestamp":1722938787000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05473-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5473"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05473-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]},"assertion":[{"value":"8 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was carried out according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committees of Sun Yat-Sen University Cancer Center (NO. B2023-554-01).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"742"}}